Iridex (IRIX) Capital Expenditures Growth (3y) (2014 - 2026)
Iridex (IRIX) Capital Expenditures Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 9.52% |
| 10 | Iridex | 13.32 Mn | 8.64 Mn | 4.30 Mn | -36.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 32.93% |
| Jan 3, 2026 | -69.49% |
| Sep 27, 2025 | -39.34% |
| Jun 28, 2025 | -27.50% |
| Mar 29, 2025 | -78.55% |
| Dec 28, 2024 | -2.07% |
| Mar 30, 2024 | 27.17% |
| Sep 30, 2023 | 58.74% |
| Jul 1, 2023 | -43.77% |
| Apr 1, 2023 | 80.79% |
| Dec 31, 2022 | 229.17% |
| Oct 1, 2022 | 76.85% |
| Jul 2, 2022 | 285.60% |
| Apr 2, 2022 | 69.72% |
| Jan 1, 2022 | -26.12% |
| Apr 3, 2021 | -58.25% |
| Sep 26, 2020 | 43.59% |
| Jun 27, 2020 | -1.79% |
| Mar 28, 2020 | -26.67% |
| Dec 28, 2019 | -77.69% |